Skip to main content

Articles

Page 4 of 76

  1. Increasing evidence highlights the potential role of long non-coding RNAs (lncRNAs) in the biological behaviors of renal cell carcinoma (RCC). Here, we explored the mechanism of AGAP2-AS1 in the occurrence and...

    Authors: Peng Xu, Da-xiong Feng, Jun Wang, Yao-Dong Wang, Gang Xie, Bin Zhang, Xiao-Han Li, Jia-Wei Zeng and Jia-Fu Feng
    Citation: Cancer Cell International 2023 23:330
  2. Cervical cancer is a leading cause of gynecological cancer death in the world. Human papillomavirus (HPV) is the most causative factor of cervical cancer. In addition, many genetic factors are involved in cerv...

    Authors: Li Li, Yixin Tong, Jianhong Wu and Xiangshang Xu
    Citation: Cancer Cell International 2023 23:329
  3. Chimeric antigen receptor (CAR) T-cells have revolutionized the treatment of CD19- and B-cell maturation antigen-positive haematological malignancies. However, the effect of a CAR construct on the function of ...

    Authors: Gerard J. Chu, Charles G. Bailey, Rajini Nagarajah, Sharon M. Sagnella, Stephen Adelstein and John E. J. Rasko
    Citation: Cancer Cell International 2023 23:327
  4. Fibroblasts, especially cancer-associated fibroblasts (CAFs), represent the predominant stromal cell population in the tumor microenvironment and have an important function in tumorigenesis by interacting with...

    Authors: Wei Cheng, Yonghui Liao, Yuan Xie, Qinrong Wang, Leilei Li, Yuanjia Chen, Yan Zhao and Jianjiang Zhou
    Citation: Cancer Cell International 2023 23:326
  5. Melanoma, a severe form of skin cancer, poses significant health risks due to its aggressive nature and potential for metastasis. The role of two-pore channel 2 (TPC2) in the development and progression of mel...

    Authors: Ali Hanbashi, Moureq Alotaibi, Homood M. As Sobeai, Lama Binobaid, Khalid Alhazzani, Xuhui Jin, Faroq Kamli, Ali Alhoshani and John Parrington
    Citation: Cancer Cell International 2023 23:325
  6. There has been a growing global interest in the potential health benefits of edible natural bioactive products in recent years. Ganoderma lucidum, a medicinal mushroom, has gained attention for its decadent array...

    Authors: Xiaoli Gao and Mina Homayoonfal
    Citation: Cancer Cell International 2023 23:324
  7. Breast cancer is the leading cause of cancer death for women worldwide. Most of the breast cancer death are due to disease recurrence and metastasis. Increasingly accumulating evidence indicates that mitochond...

    Authors: Yang Wang, Jieyi Wang, Lan Chen, Zhuo Chen, Tong Wang, Shuting Xiong, Tong Zhou, Guang Wu, Licai He, Jiawei Cao, Min Liu, Hongzhi Li and Haihua Gu
    Citation: Cancer Cell International 2023 23:323
  8. Lung cancer is the leading cause of cancer-related death. Lysosomes are key degradative compartments that maintain protein homeostasis. In current study, we aimed to construct a lysosomes-related genes signatu...

    Authors: Dingli Song, Lili Zhao, Guang Zhao, Qian Hao, Jie Wu, Hong Ren and Boxiang Zhang
    Citation: Cancer Cell International 2023 23:322
  9. Artificial intelligence (AI) is capable of integrating a large amount of related information to predict therapeutic relationships such as disease treatment with known drugs, gene expression, and drug-target bi...

    Authors: Na Ly Tran, Hyerim Kim, Cheol-Hee Shin, Eun Ko and Seung Ja Oh
    Citation: Cancer Cell International 2023 23:321
  10. Colorectal neoplasms are one of the deadliest diseases among all cancers worldwide. Thymoquinone (TQ) is a natural compound of Nigella sativa that has been used in traditional medicine against a variety of acute/...

    Authors: Farhad Sheikhnia, Vahid Rashidi, Hossein Maghsoudi and Maryam Majidinia
    Citation: Cancer Cell International 2023 23:320
  11. CD56 has been observed in malignant tumours exhibiting neuronal or neuroendocrine differentiation, such as breast cancer, small-cell lung cancer, and neuroblastoma. Abnormal glycosylation modifications are tho...

    Authors: Yuli Jian, Lin Zhang, Li Gong, Mengting Ding, Xiaoxin Sun, Xiao Yu, Shaohui Lv, Jinjing Li, Deyong Yang and Shujing Wang
    Citation: Cancer Cell International 2023 23:319
  12. Gallbladder cancer (GBC) is a prevalent and deadly biliary tract carcinoma, often diagnosed at advanced stages with limited treatment options. The 5-year survival rate varies widely from 4 to 60%, mainly due t...

    Authors: Francisco Rodas, Jetzabel A. Vidal-Vidal, Daniela Herrera, David A. Brown-Brown, Diego Vera, Joaquín Veliz, Pilar Püschel, José I. Erices, Verónica Sánchez Hinojosa, Julio C. Tapia, Eduardo Silva-Pavez, Claudia Quezada-Monrás, Pablo Mendoza-Soto, Flavio Salazar-Onfray, Cristian Carrasco and Ignacio Niechi
    Citation: Cancer Cell International 2023 23:318
  13. Gastric cancer (GC) is the fifth most common malignancy and the third leading cause of cancer-related deaths worldwide. Similar to other types of tumors, GC cells undergo metabolic reprogramming and switch to ...

    Authors: Shanshan Zheng, Huaizhi Li, Yaqi Li, Xu Chen, Junyu Shen, Menglin Chen, Cancan Zhang, Jian Wu and Qingmin Sun
    Citation: Cancer Cell International 2023 23:317
  14. Gliomas, a prevalent form of primary brain tumors, are linked with a high mortality rate and unfavorable prognoses. Disulfidptosis, an innovative form of programmed cell death, has received scant attention con...

    Authors: Di Chen, Qiaoqiao Li, Yuan Xu, Yanfei Wei, Jianguo Li, Xuqiang Zhu, Hongjiang Li, Yan Lu, Xianzhi Liu and Dongming Yan
    Citation: Cancer Cell International 2023 23:316
  15. Type I interferons (IFNs) play a central role not only in innate immunity against viral infection, but also in the antitumour response, e.g. through a direct impact on cell proliferation. Particularly for canc...

    Authors: Felix Hiebinger, Aiste Kudulyte, Huanting Chi, Sebastian Burbano De Lara, Doroteja Ilic, Barbara Helm, Hendrik Welsch, Viet Loan Dao Thi, Ursula Klingmüller and Marco Binder
    Citation: Cancer Cell International 2023 23:315
  16. This study aims to compare the technical performance of Abbott’s UroVysion and Biocare’s CytoFISH urine cytology probe panel and position the CytoFISH probe panel as an alternative to UroVysion. The CytoFISH p...

    Authors: Tammy Anderson, Sharon Hartman, William Dunn, Harvey Bellin, Thomas W. Ehlers, Sarah Groen and Jason A. Ramos
    Citation: Cancer Cell International 2023 23:314
  17. Immune checkpoint blockade (ICB) has become a promising strategy in treating advanced cancers, providing significant survival benefits for patients with various cancer types. However, among the vast population...

    Authors: Boyu Sun, Ziyu Xun, Nan Zhang, Kai Liu, Xiangqi Chen and Haitao Zhao
    Citation: Cancer Cell International 2023 23:313
  18. The metastasis of melanoma cells to regional lymph nodes and distant sites is an important contributor to cancer-related morbidity and mortality among patients with melanoma. This intricate process entails dyn...

    Authors: Azadeh Rahimi, Zahra Malakoutikhah, Ilnaz Rahimmanesh, Gordon A. Ferns, Reza Nedaeinia, Sayed Mohammad Matin Ishaghi, Nasim Dana and Shaghayegh Haghjooy Javanmard
    Citation: Cancer Cell International 2023 23:312
  19. Histone chaperones (HCs) are crucial for governing genome stability and gene expression in multiple cancers. However, the functioning of HCs in the tumor microenvironment (TME) is still not clearly understood.

    Authors: Jindong Xie, Wei Deng, Xinpei Deng, Jie-Ying Liang, Yuhui Tang, Jun Huang, Hailin Tang, Yutian Zou, Huamao Zhou and Xiaoming Xie
    Citation: Cancer Cell International 2023 23:311
  20. This work compared the metabolic profile of a parental MDA-MB-231 cisplatin-sensitive triple negative breast cancer (TNBC) cell line with that of a derived cisplatin-resistant line, to characterize inherent me...

    Authors: Tatiana J. Carneiro, Ana L. M. Batista Carvalho, Martin Vojtek, Inês F. Carmo, Maria Paula M. Marques, Carmen Diniz and Ana M. Gil
    Citation: Cancer Cell International 2023 23:310
  21. Hepatocellular carcinoma (HCC) has a high incidence and mortality rate despite various treatment options, including 125I seed implantation. However, recurrence and radiation resistance remain challenging issues. ...

    Authors: Pan Hu, Letao Lin, Tao Huang, Zhenyu Li, Meigui Xiao, Huanqing Guo, Guanyu Chen, Dengyao Liu, Miaola Ke, Hongbo Shan, Fujun Zhang and Yanling Zhang
    Citation: Cancer Cell International 2023 23:308
  22. The HAND2-AS1 (HAND2 Antisense RNA 1) Long noncoding RNA (lncRNA) has emerged as a participant in the initiation of various cancer types, underscoring its pivotal involvement in both oncological processes and ...

    Authors: Pouria Samadi, Mina Shahnazari, Abolfazl Shekari, Fatemeh Maghool and Akram Jalali
    Citation: Cancer Cell International 2023 23:307
  23. Lymphocyte-activation gene 3 (LAG3) is a recently discovered immune checkpoint molecule that has been linked to immunosuppression and the advancement of cancer in different types of solid tumors. This study ai...

    Authors: Rongyang Li, Jianhao Qiu, Zhan Zhang, Chenghao Qu, Zhanpeng Tang, Wenhao Yu, Yu Tian and Hui Tian
    Citation: Cancer Cell International 2023 23:306
  24. High recurrence and metastasis rates and poor prognoses are the major challenges of current cancer therapy. Mounting evidence suggests that cancer stem cells (CSCs) play an important role in cancer development...

    Authors: Qiuping Liu, Zongliang Guo, Guoyin Li, Yunxia Zhang, Xiaomeng Liu, Bing Li, Jinping Wang and Xiaoyan Li
    Citation: Cancer Cell International 2023 23:305
  25. Gastric cancer (GC) causes millions of cancer-related deaths due to anti-apoptosis and rapid proliferation. However, the molecular mechanisms underlying GC cell proliferation and anti-apoptosis remain unclear....

    Authors: Lei Xiao, Yang zhang, Qingqing Luo, Cao Guo, Zihua Chen and Chen Lai
    Citation: Cancer Cell International 2023 23:304
  26. Glucose transporter 3 (GLUT3) plays a major role in glycolysis and glucose metabolism in cancer cells. We aimed to investigate the correlation between GLUT3 and histone lactylation modification in the occurren...

    Authors: Hao Yang, Shifeng Yang, Jixing He, Wenqiang Li, Ange Zhang, Nana Li, Guangkai Zhou and Boshi Sun
    Citation: Cancer Cell International 2023 23:303
  27. Acute myeloid leukemia (AML) with FMS-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD) mutation accounts for a large proportion of AML patients and diagnosed with poor prognosis. Although the prog...

    Authors: Xinhua Xiao, Peihong Wang, Weina Zhang, Jiayi Wang, Mansi Cai, Hua Jiang, Yingli Wu and Huizhuang Shan
    Citation: Cancer Cell International 2023 23:302
  28. T lymphoma invasion and metastasis 1 (Tiam1) is a tumor related gene that specifically activates Rho-like GTPases Rac1 and plays a critical role in the progression of various malignancies. Glycolysis plays an ...

    Authors: Ying Liu, Aihua Jin, Xianglan Quan, Xionghu Shen, Houkun Zhou, Xingyu Zhao and Zhenhua Lin
    Citation: Cancer Cell International 2023 23:301
  29. Glucose metabolism is associated with the development of cancers, and m6A RNA methylation regulator-related genes play vital roles in bladder urothelial carcinoma (BLCA). However, the role of m6A-related gluco...

    Authors: Guanwen Zhou, Yi Li, Xiangguo Ren, Guoliang Qin, Zhaocun Zhang, Haifeng Zhao, Lijian Gao and Xianzhou Jiang
    Citation: Cancer Cell International 2023 23:300
  30. Brain metastasis is a common complication among patients with lung cancer, yet the underlying mechanisms remain unclear. In this study, we aimed to investigate the pathogenesis of brain metastasis in lung cancer.

    Authors: Jung Eun Lee, Jihye Park, Eun Ju Kim, Yoon Ho Ko, Soon Auck Hong, Seung Ho Yang and Young-Ho Ahn
    Citation: Cancer Cell International 2023 23:299
  31. Methyltransferase-like 3 (METTL3) is the key subunit of methyltransferase complex responsible for catalyzing N6-methyladenosine (m6A) modification on mRNA, which is the most prevalent post-transcriptional modific...

    Authors: Qingbin Liu, Jingjing Qi, Weiyang Li, Xinchen Tian, Jiaqi Zhang, Fen Liu, Xiulian Lu, Hengchang Zang, Chenqiao Liu, Changlin Ma, Yong Yu and Shulong Jiang
    Citation: Cancer Cell International 2023 23:298
  32. Acute myeloid leukemia (AML) is a clonal malignant disorder which originates from a small number of leukemia-initiating cells or leukemic stem cells (LSCs)—the subpopulation that is also the root cause of rela...

    Authors: Phatchanat Klaihmon, Sudjit Luanpitpong, Xing Kang and Surapol Issaragrisil
    Citation: Cancer Cell International 2023 23:297
  33. Colorectal cancer is a highly prevalent and deadly. The most common metastatic site is the liver. We performed a whole exome sequencing analysis of a series of metachronous colorectal cancer liver metastases (...

    Authors: Lucie Heczko, Viktor Hlaváč, Petr Holý, Pavel Dvořák, Václav Liška, Ondřej Vyčítal, Ondřej Fiala and Pavel Souček
    Citation: Cancer Cell International 2023 23:295
  34. Triple-negative breast Cancer (TNBC) is a highly malignant cancer with unclear pathogenesis. Within the tumor microenvironment (TME), cancer-associated fibroblasts (CAFs) vitally influence tumor onset and prog...

    Authors: Ganggang Wang, Hao Zhang, Xiaowei Shen, Wenzhi Jin, Xiaoliang Wang and Zhijie Zhou
    Citation: Cancer Cell International 2023 23:294
  35. The m6a demethyltransferase ALKBH5 dynamically modulates gene expression and intracellular metabolic molecules by modifying RNA m6a in cancer cells. However, ALKBH5’s function in gastric cancer (GC) has remain...

    Authors: Chunting Chen, Ertao Zhai, Yinan Liu, Yan Qian, Risheng Zhao, Yan Ma, Jianqiu Liu, Zhixin Huang, Jianhui Chen and Shirong Cai
    Citation: Cancer Cell International 2023 23:293
  36. Despite intensive developments of adoptive T cell and NK cell therapies, the efficacy against solid tumors remains elusive. Our study demonstrates that macrophage-based cell therapy could be a potent therapeut...

    Authors: Wen-Han Chuang, Evgeny Pislyagin, Liang-Yu Lin, Ekaterina Menchinskaya, Oleg Chernikov, Valery Kozhemyako, Tatiana Gorpenchenko, Igor Manzhulo, Elena Chaikina, Irina Agafonova, Alexandra Silchenko, Sergey Avilov, Valentin Stonik, Shey-Cherng Tzou, Dmitry Aminin and Yun-Ming Wang
    Citation: Cancer Cell International 2023 23:292
  37. Lack of Schlafen family member 11 (SLFN11) expression has been recently identified as a dominant genomic determinant of response to DNA damaging agents in numerous cancer types. Thus, several strategies aimed ...

    Authors: Christophe Michel Raynaud, Eiman I. Ahmed, Ayesha Jabeen, Apryl Sanchez, Shimaa Sherif, Tatiana C. Carneiro-Lobo, Amany Awad, Dina Awartani, Adviti Naik, Remy Thomas, Julie Decock, Gabriele Zoppoli, Davide Bedongnetti and Wouter R. L. Hendrickx
    Citation: Cancer Cell International 2023 23:291
  38. The aim of this study was to explore the associations of RIPK1 polymorphisms, plasma levels and mRNA expression with susceptibility to epithelial ovarian cancer (EOC) and clinical outcome.

    Authors: Xuedong Wang, Kui Deng, Jing Tao, Juan Zou, Yiting Du and Li Dai
    Citation: Cancer Cell International 2023 23:290
  39. Protein tripartite motif-containing 21 (TRIM21/Ro52), an E3 ubiquitin ligase, is an essential regulator of innate immunity, and its dysregulation is closely associated with the development of autoimmune diseas...

    Authors: Chueh-Hsuan Hsu and Yung-Luen Yu
    Citation: Cancer Cell International 2023 23:289
  40. CircRNAs, a special type of noncoding RNAs characterized by their stable structure and unique abilities to form backsplicing loops, have recently attracted the interest of scientists. These RNAs are abundant t...

    Authors: Chunjie Huang, Pooya Esfani Sarafraz, Parisa Enayati, Elham Mortazavi Mamaghani, Emad Babakhanzadeh and Majid Nazari
    Citation: Cancer Cell International 2023 23:288

    The Correction to this article has been published in Cancer Cell International 2024 24:40

  41. Osteosarcoma (OS) commonly metastasizes to the lung, yet the underlying molecular mechanisms remain poorly understood. Exosomes play a crucial role in tumor migration, including OS lung migration. However, the...

    Authors: Xinyu Chang, Qiuyu Tan, Jinwen Xu, Xu Wu, Ying Wang, Yuan Zhang, Hao Zhang, Haijun Liu and Liang Yan
    Citation: Cancer Cell International 2023 23:287
  42. Chemoresistance is a major clinical challenge that leads to tumor metastasis and poor clinical outcome. The mechanisms underlying gastric cancer resistance to chemotherapy are still unclear.

    Authors: Long-Long Cao, Yu-Kai Wu, Tong-Xin Lin, Mi Lin, Yu-Jing Chen, Ling-Qian Wang, Jia-Bin Wang, Jian-Xian Lin, Jun Lu, Qi-Yue Chen, Ru-Hong Tu, Ze-Ning Huang, Ju-Li Lin, Hua-Long Zheng, Jian-Wei Xie, Ping Li…
    Citation: Cancer Cell International 2023 23:286
  43. TSTA3 gene encoding GDP-l-fucose synthase has recently been proved to be closely related to the prognosis of patients with various tumors. However, its role in lung cancer is still unclear. The purpose of this st...

    Authors: Yanlin Guo, Yanlong Hao, Liuyi Shen, Yu Du, Xiaohui Wang, Lvye Gao, Xuefei Feng, Yuanfang Zhai, Zhifei Liu, Enwei Xu, Yue Yang, Yanfeng Xi, Bin Yang and Ling Zhang
    Citation: Cancer Cell International 2023 23:285
  44. Carcinoma of the lung is among the most common types of cancer globally. Concerning its histology, it is categorized as a non-small cell carcinoma (NSCLC) and a small cell cancer (SCLC) subtype. MicroRNAs (miR...

    Authors: Mohammad Saleh Sadeghi, Mohadeseh lotfi, Narges Soltani, Elahe Farmani, Jaime Humberto Ortiz Fernandez, Sheida Akhlaghitehrani, Safaa Hallol Mohammed, Saman Yasamineh, Hesam Ghafouri Kalajahi and Omid Gholizadeh
    Citation: Cancer Cell International 2023 23:284
  45. Hsa_circ_0022383 (circ_0022383) is a newly discovered circRNA. Its functions and relevant molecular mechanisms in tumorigenesis have not been reported. Here we aimed to explore how circ_0022383 regulates the t...

    Authors: Xiaofang Xu, Binbin Song, Qiuliang Zhang, Weibo Qi and Yufen Xu
    Citation: Cancer Cell International 2023 23:282

Annual Journal Metrics

  • 2022 Citation Impact
    5.8 - 2-year Impact Factor
    5.6 - 5-year Impact Factor
    0.994 - SNIP (Source Normalized Impact per Paper)
    1.145 - SJR (SCImago Journal Rank)

    2023 Speed
    34 days submission to first editorial decision for all manuscripts (Median)
    110 days submission to accept (Median)

    2023 Usage 
    2,067,719 downloads
    1,052 Altmetric mentions 

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here